康方生物:SUMMIT与PFIZER携手探索AK112联用ADC

中金公司
26 Feb

公司近况2 月24 日,公司合作伙伴Summit宣布,已与辉瑞达成临床试验合作协议,共同探索AK112 和辉瑞多款ADC药物在实体瘤中的联合治疗潜力。评论AK112 国际价值获肯定,探索与ADC的联用潜力。根据合作协议,辉瑞将全面负责本次合作涉及的临床试验的开展,Summit将提供AK112 供临床试验使用,辉瑞将提供多款vedotin系列ADCs药物,双方也将共同监督临床试验的进行,Summit...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10